[VRTX] YoY Quarter Result on 31-Mar-2015 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
04-May-2015
Financial Year
2015
Quarter
31-Mar-2015 [#Q1]
Profit Trend
QoQ- -12.43%
YoY- 14.56%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Revenue 640,799 714,718 398,080 138,509 118,451 328,368 438,737 6.51%
PBT 214,642 253,533 -30,617 -198,405 -231,654 -442,940 87,908 16.03%
Tax -12,659 3,985 5,485 299 803 -130,313 32 -
NP 210,263 247,756 -41,631 -198,606 -232,457 -308,016 91,590 14.84%
Tax Rate 5.90% -1.57% - - - - -0.04% -
Total Cost 430,536 466,962 439,711 337,115 350,908 636,384 347,147 3.65%
Ratio Analysis
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
NP Margin 32.81 34.66 -10.46 -143.39 -196.25 -93.80 20.88 7.81%
Per Share
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
EPS 0.83 1.01 -0.17 -0.83 -1.00 -1.43 0.44 11.15%
EPS Diluted 0.81 0.99 -0.17 -0.83 -1.00 -1.43 0.43 11.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.